Terran Orbital Stock Slips After $37M Equity Offering
Terran Orbital Corporation (NYSE:LLAP) said it has entered into a definitive securities purchase agreement for the purchase and sale of 29…
Achieve Life Sciences Announces Pricing Of $16.5M Registered Direct Offering For The Purchase And Sale Of 3M Shares Of Common Stock At A Price Of $5.50/Share
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced
Terran Orbital Announces $37.1M Registered Direct Offering
Terran Orbital Corporation (NYSE:LLAP) ("Terran Orbital" or the "Company"), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced that it
First Guaranty Bancshares, Inc. Announces $10M Private Placement Of 714,286 Shares Of Common Stock At A Price Of $14/Share
First Guaranty Bancshares, Inc. ("First Guaranty") (NASDAQ:FGBI), the holding company for First Guaranty Bank, announced today that it has completed a private placement offering of $10 million through
BIOLASE Inc. Announces Pricing Of $4.5M Underwritten Public Offering Of Series H Convertible Redeemable Preferred Stock and Warrants
BIOLASE, Inc. (NASDAQ:BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the
Biodexa Pharmaceuticals PLC Announces $3.32M Registered Direct Offering Of 22,135,922 New American Depositary Shares At A Price Of $0.15/ADS
Announces US$3.32 Million Registered Direct Offering
Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) ("Biodexa" or the "Company"), a clinical stage biopharmaceutical company developing a pipeline
Ocugen, Inc. Announces Pricing Of $16.5M Public Offering Of 30M Shares Of Common Stock
Ocugen, Inc. (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced the pricing of its underwritten public
Ambrx Announces $75M Registered Offering Of 5.4M American Depositary Shares At A Price Of $13.93/ADS
Ambrx Biopharma Inc., or Ambrx (or the "Company") (NASDAQ:AMAM), today announced that it has entered into a securities purchase agreement with clients managed by Darwin Global Management Ltd.
Dermata Therapeutics Announces $1.8M Offering Of 800,877 Shares Of Common Stock At A Price Of $2.285/Share Priced At-The-Market Under Nasdaq Rules
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESSWIRE / May 24, 2023 / Dermata Therapeutics, Inc. ("Dermata," or the